Boehringer Ingelheim

SPEVIGO

  1. Home
  2.  / 
  3. J Code
  4.  / SPEVIGO – J1747

Manufacturer:

Boehringer Ingelheim

Name:

SPEVIGO

HCPCS Code Descriptor:

Injection, spesolimab-sbzo, 1 mg

Category:

J Code

HCPCS:

J1747

NDC(s):

00597-0035-10, 51715-0660-10

Primary Type:

Unclassified

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

SPEVIGO is an Unclassified drug manufactured by Boehringer Ingelheim and administered via the Intravenous route of administration. The J Code: J1747 is aligned to the drug SPEVIGO.

Access Pricing and More By Registering

HCPCS Added Date:

4/1/23

HCPCS Effective Date:

4/1/23

HCPCS Short Description:

Inj, spesolimab-sbzo, 1 mg

Billing and Coding Guide:

https://content.boehringer-ingelheim.com/DAM/a74f1489-492f-4f04-b1a5-b00701402ebc/pc-us-132974%20spevigo%20bi%20coding%20guide%20urdc%20clm.pdf

Patient Assistance:

Not Found

SPEVIGO - J1747